(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

SYNTERACT

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

SYNTERACT

ST13

US500000090504612

Class

35

Filing

90504612

Registration

6595078

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

16

Latest update

10/11/2023

Trademark type

Word

Nice classes

35

Filing date

02/02/2021

Registration date

12/21/2021

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

12/21/2021

Last transaction

12/21/2021

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

First use anywhere

03/03/1994

First use in commerce

03/03/1994

Drawing code

4

Owner type

03

Owner location

Carlsbad, CA

Examiner

KING, LINDA

Law office

M70

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Synteract, Inc.

Representatives

MICHAEL A. GELLER DLA PIPER LLP (US)

Technical classification

Nice Classes

Class 35

Vienna Codes

No Vienna codes available.

Goods and services

Class 35

Strategic business consulting in the pharmaceuticalbiotechnology and life sciences fields; business monitoring and consulting servicesthe use of data analytics in the fields of pharmaceuticalsbiotechnology and life sciences; business consulting in the field of clinical trialsclinical data and regulatory submission management on behalf of medicalpharmaceutical and biotechnology companies to assist them with clinical researchclinical trials and applications for drug approval; regulatory submission managementassisting pharmaceutical and biotechnology companies with applications for new drugs with governmental regulatory bodies; business project management services in the fields of pharmaceuticalsbiotechnology and life sciences; business risk management in the fields of pharmaceuticalsbiotechnology and life sciences

Publications

History of USPTO decisions and trademark events.

16 publications found

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

10/11/2023

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

10/04/2023

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

03/15/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

12/21/2021

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

10/05/2021

PUBO

PUBLISHED FOR OPPOSITION

10/05/2021

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

09/15/2021

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

09/02/2021

XAEC

EXAMINER'S AMENDMENT ENTERED

09/02/2021

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

09/02/2021

GNEA

EXAMINERS AMENDMENT E-MAILED

09/02/2021

CNEA

EXAMINERS AMENDMENT -WRITTEN

09/02/2021

DOCK

ASSIGNED TO EXAMINER

08/24/2021

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

05/19/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

05/05/2021

NWAP

NEW APPLICATION ENTERED

02/05/2021

Continuous trademark protection

Get notified about every new filing that threatens SYNTERACT or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.